Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cf7f3f36d20185ce15a2d1f04d5fdc1 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 |
filingDate |
2007-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3df57606478f6c7e776af25f14b2a41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92e0bbaf4f592d3dee0338f3ce77d12f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38b5c06ca17e8364873b3fd076ac3daf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a79148a95ad1d4777b62be9e7274284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9be9f7f732945504453bd0552f2c2a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1637b9342e98b40bcc10c5a541a51c10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_640cc3a699bc26d2012d0536f657ac00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29c841e23487588f6b669c337958bb6d |
publicationDate |
2013-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2401908-T3 |
titleOfInvention |
Substituted oxindole derivative and its use as a vasopressin receptor ligand |
abstract |
Compound of the general formula (I) ** Formula * + and pharmaceutically acceptable salts and tautomeric forms thereof. |
priorityDate |
2006-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |